WHITE PAPER: A new approach to unveil drug targets at sub-cellular level
Visualize and quantify intracellular drug exposure using high-resolution SIMS and APT methodologies.
Developed by scientists from AstraZeneca, Chalmers University of Technology & University of Gothenburg, DrugSIMS™ provides accurate determination of drug exposures at sub-cellular and organelle level enabling optimized efficiency of novel therapeutics.
Related Articles
